Scientists from the University of Delaware believe that the dietary supplement nicotinamide riboside protects the brain from neurodegenerative diseases. The results of the scientists’ work were published in the journal Aging Cell.
Nicotinamide riboside is a form of vitamin B3 with ribose, a product of the enzymatic activity of yeast, which enters the body with food. The supplement has shown efficacy in cardiovascular, metabolic and neurodegenerative diseases. In addition, nicotinamide riboside as part of an amino acid supplement improves immunity and may contribute to faster recovery of patients with COVID-19.
Nicotinamide riboside stimulates the production of nicotinamide adenine dinucleotide (NAD+), which regulates redox processes and energy production. As the body ages, NAD+ production decreases, leading to obesity. This, in turn, is associated with other negative habits. In sum, all this is associated with an increased risk of developing neurodegenerative diseases.
According to scientists, the supplement can be used to slow down neurodegenerative processes. The team plans to test this in future studies.